NGM Clinical Study Site 924 — Los Angeles, California

NGM Clinical Study Site 924 is a clinical research site located in Los Angeles, California, United States 90057.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NGM Clinical Study Site 924 has participated in 1 clinical trials.

Therapeutic areas: Nonalcoholic Steatohepatitis (NASH).

Sponsors: NGM Biopharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NGM Clinical Study Site 924?

NGM Clinical Study Site 924 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NGM Clinical Study Site 924 conducted?

NGM Clinical Study Site 924 has 1 clinical trials on record. Their work covers Nonalcoholic Steatohepatitis (NASH).

Is NGM Clinical Study Site 924 accredited by Crixeo Health?

NGM Clinical Study Site 924 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NGM Clinical Study Site 924?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.